Clinical Trial Update: Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab

View source ↗

Summary

The update examines safety of allogeneic hematopoietic cell transplantation in patients with classical Hodgkin lymphoma who were treated with nivolumab, reporti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Opdivo (nivolumab) (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lymphoma | Status: COMPLETED